Antiretroviral Drugs as the Linchpin for Prevention of HIV Infections in the United States

Datos Bibliográficos

ID11035971
AutoresTaraz Samandari (0000-0003-4830-6108, All of the authors are with the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.), Norma Harris (0000-0001-9587-0591, All of the authors are with the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.), Janet C Cleveland (All of the authors are with the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.), David W Purcell (0000-0001-8125-5168, All of the authors are with the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.), Eugene Mccray (0000-0003-3665-0040, All of the authors are with the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.)
Año2017
Volumen107
Número10
Páginas1577-1579
Fecha de publicación2017-10-01
Peer ReviewedSí
Open AccessNo
TipoARTICLE
RevistaAmerican Journal of Public Health (JOURNAL)
Identificadores de la revistaISSN: 0090-0036 • E-ISSN: 1541-0048
EditorialAmerican Public Health Association (PUBLISHER • US)
DOI10.2105/ajph.2017.304011
IdiomaEN
Citas recibidas1
Referencias citadas4